Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. The Third Consensus Conference on the treatment of aplastic anemia

    ... Bone Marrow Diseases:  aplastic anemia ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Immunosuppression or immunostimulation for aplastic anemia? A blast from the past.

    ... Bone Marrow Diseases:  aplastic anemia ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. Allogeneic BM transplantation for the treatment of aplastic anemia: current results and expanding donor possibilities

    ... Bone Marrow Diseases:  aplastic anemia ...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.

    ... Bone Marrow Diseases:  aplastic anemia ...

    Research Article last updated 07/20/2018 - 5:15pm.

  5. Successful bone marrow transplantation for children with aplastic anemia based on a best-available evidence strategy.

    ... Bone Marrow Diseases:  aplastic anemia ...

    Research Article last updated 07/20/2018 - 5:14pm.

  6. Functional characterization of CD4+ T cells in aplastic anemia

    ... Bone Marrow Diseases:  aplastic anemia ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. Aplastic Anemia: Alternative Immunosuppressive Treatments and Eltrombopag. A report from the 2014 EBMT Educational Meeting from the Severe Aplastic Anaemia and Infectious Diseases Working Parties

    ... Bone Marrow Diseases:  aplastic anemia ...

    Research Article last updated 07/20/2018 - 5:15pm.

  8. Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia

    ... Aplastic anemia (AA), a potentially fatal disease, may be cured with marrow ... for the acquired AA patients is 82%, and for the Fanconi anemia patients it is 58% (P = .01). Multivariate analysis demonstrated ...

    Research Article last updated 07/20/2018 - 5:14pm.

  9. A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data

    ... minor-PNH+ patients, the population was divided into anemia , malignancy, infection, and normal groups. Parameters exhibiting a ... rates were: PNH (86.0%), minor-PNH+ (33.3%), others (5.0%), anemia (13.4%), malignancy (5.3%), infection (3.7%), normal (0.0%); within ...

    Research Article last updated 07/20/2018 - 5:15pm.

  10. Dr. Komrokji on the Changing Landscape of AML

    ... investigator, MDS Research Consortium, Aplastic Anemia and MDS International Foundation, clinical director, Hematologic ...

    Article last updated 09/10/2018 - 11:55am.